Powered by: Motilal Oswal
2025-12-10 11:50:13 am | Source: Accord Fintech
Anupam Rasayan India rises on inking pact to acquire 100% stake in Jayhawk Fine Chemicals
Anupam Rasayan India rises on inking pact to acquire 100% stake in Jayhawk Fine Chemicals

Anupam Rasayan India is currently trading at Rs 1319.85, up by 25.70 points or 1.99% from its previous closing of Rs 1294.15 on the BSE.

The scrip opened at Rs 1310.00 and has touched a high and low of Rs 1333.30 and Rs 1310.00 respectively. So far 14086 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 10 has touched a 52-week high of Rs 1,333.30 on 09-Dec-2025 and a 52-week low of Rs 600.95 on 28-Feb-2025.

Last one week high and low of the scrip stood at Rs 1333.30 and Rs 1111.05 respectively. The current market cap of the company is Rs 15135.56 crore.

The promoters holding in the company stood at 59.07%, while Institutions and Non-Institutions held 9.00% and 31.92% respectively.

Anupam Rasayan India has signed definitive agreement to acquire 100% equity stake in Jayhawk Fine Chemicals Corporation (Jayhawk) (part of the CABB group), a U.S. based specialty chemical company, for a purchase consideration of around $150 million. The purchase consideration accounts for payment against the equity value of Jayhawk and existing loans payable to the exiting shareholders. Considering around $16 million of cash and cash-like items for Jayhawk as of June 2025, the purchase consideration translates to an enterprise value of around $134 million. 

The acquisition will be financed through a mix of internal accruals, debt and quasi equity from a leading global investment management firm with an AUM in excess of $100 billion. This acquisition shall be EPS accretive for Anupam.

This acquisition represents a transformative step in Anupam Rasayan’s long-term strategy to expand its global CDMO presence and establish a strong foothold in the U.S. & global specialty chemicals market.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here